Qi Lei, Yuan Bo, Fu Qiang
Tianjin Medical University, Tianjin 300070, China. Corresponding author: Fu Qiang, Tianjin Fourth Centre Hospital, Tianjin 300140, China, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jun;26(6):409-14. doi: 10.3760/cma.j.issn.2095-4352.2014.06.009.
To observe pathological process of intestinal epithelial cells subjected to ischemia, ischemia/reperfusion injury and inflammation simulated hypoxia/reoxygenation (H/R) and lipopolysaccharide (LPS) challenged human fetal normal colonic cell (FHC) line in vivo, and to observe the changes when the assaulted intestinal epithelial cells were treated with emodin, in order to explore the possible intervention targets of emodin.
Normoxia group: the FHC cells were cultured in 95% air and 5% CO2 at 37 centigrade. Hypoxia (H) group: the cells were cultured with a mixed anaerobic gas of 1% O2, 5% CO2 and 94% N2 at 37 centigrade for 1, 2, 3, 4 hours. H + LPS group: the cells were cultured in hypoxic condition as H group with simultaneous challenge of LPS (1 mg/L). H/R group: the cells were cultured in hypoxia for 3 hours followed by reoxygenation for 1, 2, 3 and 4 hours, respectively. H/R + LPS group: the cells were cultured in H/R as H/R group and LPS (1 mg/L) simultaneously. Emodin intervention group: the cells were cultured in H3 h/R2 h + LPS and emodin (20, 40, 60, 80 μmol/L) simultaneously. The variation trends of phosphorylation nuclear factor-ΚB profilin-α (pIΚB-α), phosphorylation NF-ΚBp65 (pNF-ΚBp65) and their downstream target gene cyclooxygenase-2 (COX-2), and hypoxia-inducible factor-1α (HIF-1α) were determined by Western Blot. The morphological changes in intestinal epithelium in different groups were observed using light microscope. The effect of emodin on the proliferation of intestinal epithelial cell was measured by methyl thiazolyl tetrazolium (MTT) assay.
(1) H group: the expressions of pIΚB-α, pNF-ΚBp65 and COX-2 were upregulated, peaking at H1 h (0.350 ± 0.018, 1.083 ± 0.054, 0.903 ± 0.045), and then they gradually lowered (F value was 3.011, 7.247, 5.754, P value was 0.013, 0.000, 0.005, respectively). The expression of HIF-1α peaked at H3 h (1.511±0.076), but there was no significant difference among different groups (F=1.881, P=0.062). H + LPS group: the expressions of pIΚB-α, pNF-ΚBp65, COX-2, HIF-1α were increased with elongation of duration of hypoxia, and a maximal induction was observed at H3 h (0.504 ± 0.025, 1.255 ± 0.063, 0.812 ± 0.041, 1.209 ± 0.075, F value was 2.683, 8.774, 9.765, 2.432, and P value was 0.011, 0.000, 0.000, 0.026, respectively). H/R group: with the prolonged duration of reoxygenation, the expressions of NF-ΚB signaling pathway proteins (pIΚB-α, pNF-ΚBp65, COX-2) were decreased and dropped to nadir at H3 h/R4 h (0.712±0.034, 1.202±0.048, 0.691±0.042, F value was 1.923, 6.765, 2.719, and P value was 0.063, 0.000, 0.016, respectively). Compared with H group, HIF-1α was decreased with a prolonged duration of reoxygenation in H/R group, but there was no significant difference in value among different time points (F=1.280, P=0.081). H/R + LPS group: pIΚB-α, pNF-ΚBp65, COX-2, HIF-1α showed no sign of degradation with the prolonged duration of reoxygenation, and their expression increased to maximum analogously at R2-3 h (3.302±0.061, 2.315±0.055, 2.017±0.043, 2.413±0.098, F value was 4.614, 1.652, 5.970, 2.076, and P value was 0.001, 0.067, 0.000, 0.037, respectively). Emodin group: emodin when co-treated with H/R + LPS inhibited the expression of HIF-1α and NF-ΚB pathways with a dose-effect relationship (P<0.05 or P<0.01). Emodin at the dose of 80 μmol/L showed most marked inhibition (2.599±0.130, 1.772±0.089, 2.590±0.129, 2.518±0.125). However, after treatment of emodin did not show such effect. (2) After treatment with H/R + LPS, there were morphological changes in cells: vacuoles, deformation and fusion. The speed of cell growth became much slower compared with H group. (3) Emodin (20-80 μmol/L) had no significant effect on cell proliferation. Although emodin produced biological effect in this concentration range, it had no cellular toxicity.
Both hypoxia and inflammation can activate the hypoxia pathway of HIF-1α and the pro-inflammatory pathway of NF-ΚB, but different stimuli cause varying degrees of activation in these two pathways. In H/R group, both pathways were weakened during reoxygenation. However, in H/R + LPS group, the proteins remained to show a relatively high expression during the process of reoxygenation. This may be related to the pathophysiological mechanism of intestinal ischemia/reperfusion injury: hypoxia/reperfusion injury and LPS act together to destroy the intestinal epithelial cells and induce gut-derived sepsis. Emodin may inhibit inflammation by blocking HIF-1α/NF-ΚB-COX-2 signaling pathways.
观察人胎儿正常结肠细胞(FHC)系在体内模拟缺血、缺血/再灌注损伤及炎症的缺氧/复氧(H/R)和脂多糖(LPS)刺激下肠上皮细胞的病理过程,并观察受攻击的肠上皮细胞用大黄素处理后的变化,以探索大黄素可能的干预靶点。
常氧组:FHC细胞在37℃、95%空气和5%二氧化碳条件下培养。缺氧(H)组:细胞在37℃用含1%氧气、5%二氧化碳和94%氮气的混合厌氧气体培养1、2、3、4小时。H + LPS组:细胞在缺氧条件下如H组培养,同时给予LPS(1 mg/L)刺激。H/R组:细胞先缺氧培养3小时,然后分别复氧1、2、3、4小时。H/R + LPS组:细胞按H/R组进行缺氧/复氧培养,并同时给予LPS(1 mg/L)。大黄素干预组:细胞在H3 h/R2 h + LPS条件下培养,并同时加入大黄素(20、40、60、80 μmol/L)。采用蛋白质免疫印迹法检测磷酸化核因子-κB抑制蛋白-α(pIκB-α)、磷酸化NF-κBp65(pNF-κBp65)及其下游靶基因环氧化酶-2(COX-2)和缺氧诱导因子-1α(HIF-1α)的变化趋势。用光镜观察不同组肠上皮的形态变化。采用甲基噻唑基四氮唑(MTT)法检测大黄素对肠上皮细胞增殖的影响。
(1)H组:pIκB-α、pNF-κBp65和COX-2的表达上调,在H1 h达到峰值(0.350±0.018、1.083±0.054、0.903±0.045),随后逐渐下降(F值分别为3.011、7.247、5.754,P值分别为0.013、0.000、0.005)。HIF-1α的表达在H3 h达到峰值(1.511±0.076),但不同组间差异无统计学意义(F = 1.881,P = 0.062)。H + LPS组:pIκB-α、pNF-κBp65、COX-2、HIF-1α的表达随缺氧时间延长而增加,在H3 h达到最大诱导水平(0.504±0.025、1.255±0.063、0.812±0.041、1.209±0.075,F值分别为2.683、8.774、9.765、2.432,P值分别为0.011、0.000、0.000、0.026)。H/R组:随着复氧时间延长,NF-κB信号通路蛋白(pIκB-α、pNF-κBp65、COX-2)的表达下降,在H3 h/R4 h降至最低点(0.712±0.034、1.202±0.048、0.691±0.042,F值分别为1.923、6.765、2.719,P值分别为0.063、0.000、0.016)。与H组相比,H/R组中HIF-1α随复氧时间延长而降低,但不同时间点差异无统计学意义(F = 1.280,P = 0.081)。H/R + LPS组:随着复氧时间延长,pIκB-α、pNF-κBp65、COX-2、HIF-1α无降解迹象,在复氧2 - 3小时类似地增加到最大值(3.302±0.061、2.315±0.055、2.017±0.043、2.413±0.098,F值分别为4.614、1.652、5.970、2.076,P值分别为0.001、0.067、0.000、0.037)。大黄素组:大黄素与H/R + LPS共同处理时抑制HIF-1α和NF-κB通路的表达,呈剂量效应关系(P < 0.05或P < 0.01)。80 μmol/L剂量的大黄素抑制作用最明显(2.599±0.130、1.772±0.089、2.590±0.129、